The apo E gene knockout mouse as a model to study the potential atherogenic properties of glycosphingolipids

The apo E gene knockout mouse as a model to study the potential atherogenic properties of glycosphingolipids

Bibliographic Details
Main Authors:	Garner, B, Priestman, D, Stocker, R, Harvey, D, Butters, T, Platt, F
Format:	Conference item
Published:	2003

Similar Items

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.
by: Garner, B, et al.
Published: (2002)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
by: Brett Garner, et al.
Published: (2002-02-01)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
by: Priestman, D, et al.
Published: (2008)

An MRI technique for the quantification of atherosclerotic lesions in the ApoE knockout mouse
by: Grieve, S, et al.
Published: (2002)

Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.
by: Pei, B, et al.
Published: (2011)

Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of mouse brain
by: Hallett, PJ, et al.
Published: (2018)

Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis.
by: Mellor, H, et al.
Published: (2004)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
by: Butters, T, et al.
Published: (2003)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
by: Butters, T, et al.
Published: (2000)

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling.
by: Neville, D, et al.
Published: (2004)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
by: Jeyakumar, M, et al.
Published: (2002)

Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
by: Platt, F, et al.
Published: (2000)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
by: Garner, B, et al.
Published: (2002)

New developments in treating glycosphingolipid storage diseases.
by: Platt, F, et al.
Published: (2005)

Glycosphingolipid disorders of the brain.
by: Boomkamp, S, et al.
Published: (2008)

Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
by: Wallom, K-L, et al.
Published: (2021)

Glycosphingolipids in endocytic membrane transport.
by: Sillence, D, et al.
Published: (2004)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
by: Silk, J, et al.
Published: (2005)

Introduction: Glycosphingolipids in cell biology and disease.
by: Sillence, D, et al.
Published: (2004)

A mouse systems genetics approach reveals common and uncommon genetic modifiers of hepatic lysosomal enzyme activities and glycosphingolipids
by: Durán, A, et al.
Published: (2023)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
by: Gadola, S, et al.
Published: (2006)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
by: Andersson, U, et al.
Published: (2000)

Glycosphingolipid changes in plasma in Parkinson’s disease independent of glucosylceramide levels
by: te Vruchte, D, et al.
Published: (2022)

A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids
by: Anyelo Durán, et al.
Published: (2023-03-01)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
by: van der Spoel, A, et al.
Published: (2002)

Kefir peptides attenuate atherosclerotic vascular calcification and osteoporosis in atherogenic diet-fed ApoE−/− knockout mice
by: Gary Ro-Lin Chang, et al.
Published: (2023-04-01)

Substrate reduction therapy for glycosphingolipid storage disorders.
by: Lachmann, R, et al.
Published: (2001)

Apoptotic modification of glycosphingolipids of human granulocytes
by: A. M. Tomin, et al.
Published: (2012-09-01)

Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
by: Butters, T, et al.
Published: (2000)

Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation.
by: van der Spoel, A, et al.
Published: (2008)

ALTERED AUTOPHAGY AND APP METABOLISM IN GLYCOSPHINGOLIPID STORAGE DISEASES
by: Boland, B, et al.
Published: (2011)

Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
by: Boomkamp, S, et al.
Published: (2010)

Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk/cpk) mouse.
by: G D Deshmukh, et al.
Published: (1994-09-01)

Imino sugar therapy for type 1 Gaucher disease.
by: Priestman, D, et al.
Published: (2000)

Glycosphingolipids in human parasites
by: Richard D. Cummings
Published: (2023-09-01)

Micellar properties of glycosphingolipids in aqueous media.
by: B Ulrich-Bott, et al.
Published: (1984-11-01)

Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse
by: Elena Ulasova, et al.
Published: (2013-01-01)

Glycosphingolipids and Infection. Potential New Therapeutic Avenues
by: Johannes M. F. G. Aerts, et al.
Published: (2019-12-01)

Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE–/–) mice: apoE–/– mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis
by: Jiří Neužil, et al.
Published: (1998-02-01)

Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.
by: te Vruchte, D, et al.
Published: (2010)